Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Other Non-Current Liabilities (2018 - 2026)

Healthequity has reported Other Non-Current Liabilities over the past 10 years, most recently at $31.0 million for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities rose 35.04% year-over-year to $31.0 million; the TTM value through Jan 2026 reached $31.0 million, up 35.04%, while the annual FY2026 figure was $31.0 million, 35.04% up from the prior year.
  • Other Non-Current Liabilities for Q1 2026 was $31.0 million at Healthequity, up from $23.5 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $31.0 million in Q1 2026 and troughed at $9.8 million in Q4 2022.
  • A 5-year average of $18.8 million and a median of $19.3 million in 2024 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 48.51% in 2022 and later soared 94.75% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $9.8 million in 2022, then soared by 81.5% to $17.7 million in 2023, then soared by 42.71% to $25.3 million in 2024, then decreased by 7.02% to $23.5 million in 2025, then skyrocketed by 31.94% to $31.0 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for HQY at $31.0 million in Q1 2026, $23.5 million in Q4 2025, and $22.0 million in Q3 2025.